期刊文献+

COPD急性发作期患者早期SIRS评分及NT-proBNP与患者病死率的相关性研究 被引量:3

The correlation between early SIRS score and NT-pro BNP and mortality of patients with COPD acute episodes were studied
下载PDF
导出
摘要 目的探讨慢性阻塞性肺疾病(COPD)患者急性发作期的SIRS评分及N末端B型脑钠肽(NT-pro BNP)水平与患者肺功能的关系以及对患者预后的影响。方法回顾性分析COPD患者缓解期肺功能的情况进行分级,在患者急性发作期统计SIRS评分并检测NT-pro BNP水平后进行统计分析。结果 COPD患者肺功能越差急性发作期SIRS评分及NT-pro BNP水平越高,而肺功能三级和四级患者早期SIRS评分及NT-pro BNP水平对于病死率有较高的灵敏度和特异度。结论早期SIRS评分及NT-pro BNP水平对COPD患者急性发作期的预后判断具有一定临床意义,肺功能较差的患者早期SIRS评分及NT-pro BNP水平对于病死率的判断有较高的灵敏度和特异度。 Objective To investigate the SIRS score of patients with chronic obstructive pulmonary disease( COPD) and the relationship between NT-proBNP values,patients' lung function,the prognosis of patients with COPD. Methods According to the condition of the patients' remission of lung function,the statistical analysis was carried out on the statistical SIRS score and NT-proBNP number of the patients during the acute attack period. Results The worse lung function were in the acute phase SIRS,and the higher was the NT-proBNP. For patients with lung function of level 3 and level 4 patients,early SIRS score and the NT-proBNP has higher sensitivity and specificity on mortality evaluation. Conclusion The early SIRS score,the NT-proBNP level has a certain clinical significance in the prognostic judgment of COPD patients in acute phase. For patients with poor lung function,early SIRS score and the NT-proBNP level has higher sensitivity and specificity in the judgment for patient mortality evaluation.
出处 《临床和实验医学杂志》 2017年第21期2131-2133,共3页 Journal of Clinical and Experimental Medicine
关键词 COPD 肺功能分级 SIRS评分 NT-PROBNP COPD Lung function grade SIRS score NT - proBNP
  • 相关文献

参考文献4

二级参考文献38

  • 1吴尚洁,陈平,蒋惜念,刘志军.慢性阻塞性肺疾病患者C反应蛋白水平及其与肺功能变化的相关性[J].中南大学学报(医学版),2005,30(4):444-446. 被引量:45
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8229
  • 3Christ Crain M,Jaccard Stolz D, Bingisser R,et al. Effect of procalcitonin guided treatment on antibiotic use and outcome in lower respiratory tract infections : cluster randonfised, single blinded intervention trial [J]. Lancet,2004,363 ( 6 ) :600607.
  • 4Pinto-Pl ata V M, Mullerova H, Toso J F, et al. C-restive protein in patients with COPD, control smokers and non-smokers [J]. Thorax, 2006, 61 (4) :23-28.
  • 5Kitasato Y, Hoshino T, Kato S, et al. Enhanced expresssion of IL-18 and its receptor in patients with chronic obstructive pulmonary disease [J]. Proc Am Thorac Soc, 2006,3 (2) : A629.
  • 6Weis N, Almdal T. C-reactive protein-can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonaly disease? [J]. Eur J Inter Med, 2006, 17 (2) : 88-91.
  • 7Pinto-Plata V M,Mullerova H,Toso J F, et al. C-reactive protein in patients with COPD, control smokers and non-smokers [ J ]. Thorax, 2006, 6 ( 1 ) : 1-3.
  • 8Sugimoto T, Ishikawa Y, Yoshimoto T, et al. Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyper-responsiveness in a naive host mouse[J]. J Exp Med, 2004,199 ( 4 ) : 535-545.
  • 9Tsutsui H, Yoshimoto T, Hayashi N, et al. Induction of allergic. Inflammation by inter-lenkin-18 in experimental animal models[J]. Immunol Rev, 2004,202 : 115-138.
  • 10Hoshino T, Kato S, Oka N, et al. Pulmonary inflammation and emphysema: Role of the eytokines IL-18 and IL-13 [J]. Am J Respir Crit Care Med, 2007,76( 1 ) :49452.

共引文献5173

同被引文献38

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部